Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials
Open accessThe DOI matches its Crossref record; 66 of the 69 references it cites were found in a registry or an index.
Abstract
Frontotemporal dementia refers to a group of progressive neurodegenerative syndromes usually caused by the accumulation of pathological tau or TDP-43 proteins. The effects of these proteins in the brain are complex, and each can present with several different clinical syndromes. Clinical efficacy trials of drugs targeting these proteins must use endpoints that are meaningful to all participants despite the variability in symptoms across patients. There are many candidate clinical measures, including neuropsychological scores and functional measures. Brain imaging is another potentially attractive outcome that can be precisely quantified and provides evidence of disease modification. Most imaging studies in frontotemporal dementia have been cross-sectional, and few have compared longitudinal changes in cortical volume with changes in other measures such as perfusion and white matter integrity. The current study characterized longitudinal changes in 161 patients with three frontotemporal dementia syndromes: behavioural variant frontotemporal dementia (n = 77) and the semantic (n = 45) and non-fluent (n = 39) variants of primary progressive aphasia. Visits included comprehensive neuropsychological and functional assessment, structural MRI (3 T), diffusion tensor imaging, and arterial spin labelled perfusion imaging. The goal was to identify measures that are appropriate as clinical trial outcomes for each group, as well as those that might be appropriate for trials that would include more than one of these groups. Linear mixed effects models were used to estimate changes in each measure, and to examine the correlation between imaging and clinical changes. Sample sizes were estimated based on the observed effects for theoretical clinical trials using bootstrapping techniques to provide 95% confidence intervals for these estimates. Declines in functional and neuropsychological measures, as well as frontal and temporal cortical volumes and white matter microstructure were detected in all groups. Imaging changes were statistically significantly correlated with, and explained a substantial portion of variance in, the change in most clinical measures. Perfusion and diffusion tensor imaging accounted for variation in clinical decline beyond volume alone. Sample size estimates for atrophy and diffusion imaging were comparable to clinical measures. Corpus callosal fractional anisotropy led to the lowest sample size estimates for all three syndromes. These findings provide further guidance on selection of trial endpoints for studies in frontotemporal dementia and support the use of neuroimaging, particularly structural and diffusion weighted imaging, as biomarkers. Diffusion and perfusion imaging appear to offer additional utility for explaining clinical change beyond the variance explained by volume alone, arguing for considering multimodal imaging in treatment trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, the clinical diagnosis of each frontotemporal dementia (FTD) variant requires high levels of expertise and multidisciplinary teams to distinguish among subtle phenotypes with similar underlying physiopathological processes (Bejanin et al., 2020; Staffaroni et al., 2019; Zetterberg et al., 2019).”
From Multiclass characterization of frontotemporal dementia variants via multimodal brain network computational inference (2023) · cites this paper as Staffaroni et al., 2019
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Tuberous sclerosis–associated neuropsychiatric disorders symptoms overlap with clinical criteria for frontotemporal dementia, yet the association between the 2 has not been explored.”
From Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia (2020) · cites this paper as [15]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Studies of interference in serial verbal reactions
Stroop, J. R. (1935) · Journal of Experimental Psychology · doi:10.1037/h0054651 · Cited by 18,622
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Self-citation
Research works printed but not linked: 4
- Delis, 2001, Delis-Kaplan Executive Function System (DKEFS): Examiner’s manual
- Delis, 2000, California Verbal Learning Test - second edition. Adult version. Manual
- Howard, 1992, Pyramids and palm trees: A test of semantic access from pictures and words
- Schwab, 1969, Projection technique for evaluating surgery in Parkinson’s disease
Cited by
Temporal order of clinical and biomarker changes in familial frontotemporal dementia
Staffaroni, A. M., Quintana, M., Wendelberger, B., Heuer, H. W., Russell, L. L., Cobigo, Y., Wolf, A., Goh, S.-Y. M., Petrucelli, L., Gendron, T. F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01942-9 · Cited by 140
Self-citationPreventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
Benatar, M. G., Wuu, J., McHutchison, C. A., Postuma, R. B., Boeve, B. F., Petersen, R. C., Ross, C. A., Rosen, H. J., Arias, J. J., Fradette, S., et al. (2021) · Brain · doi:10.1093/brain/awab404 · Cited by 133
“95 Among the many MRI measures evaluated in cross-sectional and longitudinal studies in FTLD, 96,97–103 volumetric MRI has shown the most promise in characterizing changes during the pre-symptomatic phase of f-FTLD (FTLD-CDR score = 0), with the topography of changes depending on the mutated gene.”
Self-citationNetwork localization of clinical, cognitive, and neuropsychiatric symptoms in Alzheimer’s disease
Tetreault, A. M., Phan, T. X., Orlando, D., Lyu, I., Kang, H., Landman, B. A., Darby, R. R., & Initiative, O. B. O. A. D. N. (2020) · Brain · doi:10.1093/brain/awaa058 · Cited by 130
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders
Panza, F., Lozupone, M., Seripa, D., Daniele, A., Watling, M., Giannelli, G., & Imbimbo, B. P. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0330-x · Cited by 122
Henry, M. L., Hubbard, H. I., Grasso, S. M., Dial, H. R., Beeson, P. M., Miller, B. L., & Gorno-Tempini, M. L. (2019) · Journal of Speech, Language, and Hearing Research · doi:10.1044/2018_jslhr-l-18-0144 · Cited by 118
Self-citationBeyond the average patient: how neuroimaging models can address heterogeneity in dementia
Verdi, S., Marquand, A. F., Schott, J. M., & Cole, J. H. (2021) · Brain · doi:10.1093/brain/awab165 · Cited by 106
Staffaroni, A. M., Cobigo, Y., Elahi, F. M., Casaletto, K. B., Walters, S. M., Wolf, A. A., Lindbergh, C. A., Rosen, H. J., & Kramer, J. H. (2019) · Human Brain Mapping · doi:10.1002/hbm.24613 · Cited by 91
Self-citationYounes, K., & Miller, B. L. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.02.006 · Cited by 88
Self-citationCellular and regional vulnerability in frontotemporal tauopathies
Forrest, S. L., Kril, J. J., & Halliday, G. M. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02035-7 · Cited by 85
Longitudinal structural and metabolic changes in frontotemporal dementia
Bejanin, A., Tammewar, G., Marx, G., Cobigo, Y., Iaccarino, L., Kornak, J., Staffaroni, A. M., Dickerson, B. C., Boeve, B. F., Knopman, D. S., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009760 · Cited by 70
“Over the last decade, brain imaging has become an attractive surrogate outcome in clinical trials in neurodegenerative disorders, as imaging provides an objective biological measure of disease progression, correlates with clinical measures, and may be sensitive to preclinical disease stage.(3) To date, most longitudin…”
BackgroundSelf-citationManera, A. L., Dadar, M., Collins, D. L., & Ducharme, S. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2019.102079 · Cited by 65
“Finally, a recent study reports a required sample of 163 bvFTD subjects for 40% effect size and 418 for 25% effect size using left frontal volume as an outcome measure (12-months trial, 80% power, 5% significance and 20% potential attrition rate)[28]; these numbers are more than twice as large are those we estimate fo…”
MethodMicroglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia
Malpetti, M., Cope, T., Street, D., Jones, P. S., Hezemans, F. H., Mak, E., Tsvetanov, K. A., Rittman, T., Bevan-Jones, W. R., Patterson, K. E., et al. (2023) · Brain · doi:10.1093/brain/awad078 · Cited by 66
Rosen, H. J., Boeve, B. F., & Boxer, A. L. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12004 · Cited by 55
Self-citationFTD spectrum: Neuroimaging across the FTD spectrum
Whitwell, J. L. (2019) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2019.05.009 · Cited by 53
Asken, B. M., Tanner, J. A., VandeVrede, L. A., Casaletto, K. B., Staffaroni, A. M., Mundada, N. S., Fonseca, C. S., Iaccarino, L., Joie, R. L., Tsuei, T., et al. (2022) · Journal of Neurotrauma · doi:10.1089/neu.2022.0060 · Cited by 54
“43 We selected ROIs based on visualization of the voxel-wise W-score frequency map and previous research on DTI in RHI populations (superior longitudinal fasciculus, superior fronto-occipital fasciculus, genu of the corpus callosum, uncinate fasciculus, fornix, cingulum-hippocampal bundle) as well…”
Self-citationStaffaroni, A. M., Bajorek, L. P., Casaletto, K. B., Cobigo, Y., Goh, S. M., Wolf, A. A., Heuer, H. W., Elahi, F. M., Ljubenkov, P. A., Dever, R., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.01.012 · Cited by 52
Self-citationFrontotemporal dementias: main syndromes and underlying brain changes
Piguet, O., & Kumfor, F. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000792 · Cited by 51
Olney, N. T., Ong, E., Goh, S. M., Bajorek, L., Dever, R., Staffaroni, A. M., Cobigo, Y., Bock, M., Chiang, K., Ljubenkov, P., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.08.196 · Cited by 46
“Reference images for creation of atrophy maps were obtained from 270 control subjects, including 115 noncarrier family members from ARTFL/LEFFTDS, 63 who enrolled in prior studies of neuroimaging in FTLD at University of California San Francisco (AG032306 [17]), 34 from non–mutation carriers from the Dominantly Inheri…”
MethodSelf-citationAnatomical MRI staging of frontotemporal dementia variants
Planche, V., Mansencal, B., Manjón, J. V., Tourdias, T., Catheline, G., & Coupé, P. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12975 · Cited by 49
“13 In this study, we propose to depict the progressive anatomical staging of FTD variants.”
Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials
Street, D., Jabbari, E., Costantini, A. A., Jones, P. S., Holland, N., Rittman, T., Jensen, M. T., Chelban, V., Goh, Y. Y., Guo, T., et al. (2023) · Brain · doi:10.1093/brain/awad105 · Cited by 44
“Such comparisons have been performed in frontotemporal dementia 30,31 and Huntington’s disease 32 using the effect size of change for each assay to estimate sample sizes required for a clinical trial.”
Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia
Panman, J. L., Venkatraghavan, V., van der Ende, E. L., Steketee, R. M. E., Jiskoot, L. C., Poos, J. M., Dopper, E. G. P., Meeter, L. H. H., Kaat, L. D., Rombouts, S. A. R. B., et al. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323541 · Cited by 43
“9 10 35 In addition, we showed that left hemi-spheric tracts and regions were affected in nfvPPA patients before right regions, accordant with the previously reported strong involvement of the left hemisphere in primary progressive aphasia.”
Staffaroni, A. M., Goh, S.-Y. M., Cobigo, Y., Ong, E., Lee, S. E., Casaletto, K. B., Wolf, A., Forsberg, L. K., Ghoshal, N., Graff-Radford, N. R., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.22847 · Cited by 41
Self-citationHalai, A. D., Woollams, A. M., & Ralph, M. A. L. (2020) · Nature Human Behaviour · doi:10.1038/s41562-020-0854-5 · Cited by 46
“Accordingly, in these diseases it is not surprising that the addition of white-matter measures does improve brain–behaviour models 62 .”
BackgroundREM sleep is associated with white matter integrity in cognitively healthy, older adults
Altendahl, M., Cotter, D. L., Staffaroni, A. M., Wolf, A. A., Mumford, P., Cobigo, Y., Casaletto, K. B., Elahi, F. M., Yack, L. M., Javed, S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235395 · Cited by 42
“FA, MD, AD, and RD maps were not skeletonized, instead the mean of each metric was taken across all voxels in each tract ROI as a whole [26,37].”
BackgroundSelf-citationSchwarz, A. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01027-4 · Cited by 42
“Strong relationships between lobar atrophy and concurrent longitudinal change in several global clinical scales have also been reported in variants of frontotemporal dementia [184], and global and regional atrophy rates have been shown to correlate to different degrees with various clinical instruments in Huntington’s…”
ResultSablonnière, J. D. L., Tastevin, M., Lavoie, M., & Laforce, R. J. (2021) · Brain Sciences · doi:10.3390/brainsci11091209 · Cited by 41
“Authors (Year) Participants Study Design Follow-Up Clinical Assessment Main Results Van Langenhove et al. (2016) [31] lvPPA: n = 21 nfvPPA: n = 22 svPPA: n = 30 bvFTD: n = 33 AD: n = 31 Prospective group study 1 FU at a mean of 12 months (a) Cognition: CDR, ACE-III, CBI-R (b) BPSD: CBI-R (c) LOF: CBI-R (a) Baseline: M…”
MethodResultInfluentialQuantifying progression in primary progressive aphasia with structural neuroimaging
Lombardi, J., Mayer, B., Semler, E., Anderl‐Straub, S., Uttner, I., Kassubek, J., Diehl‐Schmid, J., Danek, A., Levin, J., Fassbender, K. C., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12323 · Cited by 38
Aquaporin 4 is differentially increased and dislocated in association with tau and amyloid-beta
Kecheliev, V., Boss, L., Maheshwari, U., Konietzko, U., Keller, A., Razansky, D., Nitsch, R. M., Klohs, J., & Ni, R. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121593 · Cited by 37
Shiells, H., Schelter, B. O., Bentham, P., Baddeley, T. C., Rubino, C. M., Ganesan, H., Hammel, J., Vuksanović, V., Staff, R. T., Murray, A. D., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191173 · Cited by 35
“Based on the present results, FAQ and Modified-CGIC appear to have the greatest power as clinical outcomes in practice, consistent with previous suggestions [75, 76], and change in whole brain [76] or lateral ventricular volume have the greatest power as supportive biomarker outcomes.”
ResultUniform data set language measures for bvFTD and PPA diagnosis and monitoring
Staffaroni, A. M., Weintraub, S., Rascovsky, K., Rankin, K. P., Taylor, J., Fields, J. A., Casaletto, K. B., Hillis, A. E., Lukic, S., Gorno‐Tempini, M. L., et al. (2021) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12148 · Cited by 33
Self-citationElahi, F. M., Ashimatey, B. S., Bennett, D. J., Walters, S. M., Joie, R. L., Jiang, X., Wolf, A. A., Cobigo, Y., Staffaroni, A. M., Rosen, H. J., et al. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12181 · Cited by 34
Self-citationBiomarkers in frontotemporal dementia: Current landscape and future directions
Gifford, A., Praschan, N. C., Newhouse, A. L., & Chemali, Z. N. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100065 · Cited by 33
Cortical microstructure in primary progressive aphasia: a multicenter study
Illán‐Gala, I., Montal, V., Borrego‐Écija, S., Mandelli, M. L., Falgàs, N., Welch, A. E., Pegueroles, J., Santos‐Santos, M., Bejanin, A., Alcolea, D. A., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00974-0 · Cited by 29
Self-citationIllán‐Gala, I., Falgàs, N., Friedberg, A., Castro‐Suárez, S., Keret, O., Rogers, N., Öz, D., Nigro, S. L., Quattrone, A., Quattrone, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.1290 · Cited by 27
Self-citationIntrahepatic cholestasis due to systemic mastocytosis: a case report and review of literature.
Safyan, E. L., Veerabagu, M. P., Swerdlow, S. H., Lee, R. G., & Rakela, J. L. (1997) · PubMed · Cited by 29
Using in vivo functional and structural connectivity to predict chronic stroke aphasia deficits
Zhao, Y., Cox, C. R., Ralph, M. A. L., & Halai, A. D. (2022) · Brain · doi:10.1093/brain/awac388 · Cited by 26
“82,83”
Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights
Scarioni, M., Gami‐Patel, P., Peeters, C. F. W., de Koning, F., Seelaar, H., Mol, M. O., Swieten, J. C. V., Bank, N. B., Rozemüller, A. J. M., Hoozemans, J. J. M., et al. (2022) · Brain · doi:10.1093/brain/awac043 · Cited by 27
Brain perfusion SPECT in dementia: what radiologists should know
Imokawa, T., Yokoyama, K., Takahashi, K., Oyama, J., Tsuchiya, J., Sanjo, N., & Tateishi, U. (2024) · Japanese Journal of Radiology · doi:10.1007/s11604-024-01612-5 · Cited by 25
“However, over time, atrophy extended to the temporal lobe contralateral to the dominant side of the atrophy, and atrophy progressed in the frontal lobe [101, 102].”
BackgroundPak, V., Adewale, Q., Bzdok, D., Dadar, M., Zeighami, Y., & Iturria‐Medina, Y. (2023) · eLife · doi:10.7554/elife.89368 · Cited by 26
Ding, W., Ren, P., Yi, L., Si, Y., Yang, F., Li, Z., Bao, H., Yan, S., Zhang, X., Li, S., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01208-7 · Cited by 22
Self-citationClinical dimensions along the non-fluent variant primary progressive aphasia spectrum
Illán‐Gala, I., Lorca‐Puls, D. L., Tee, B. L., Ezzes, Z., de Leon, J., Miller, Z., Rubio‐Guerra, S., Santos‐Santos, M., Gómez‐Andrés, D., Grinberg, L. T., et al. (2023) · Brain · doi:10.1093/brain/awad396 · Cited by 21
“56 We fitted a linear mixed-effects model controlling for age, sex and the most relevant clinical features to estimate clinical decline over time (as measured by CDR-SB or CDR plus NACC FTLD-SB) across our patient sample.”
MethodSelf-citationLukic, S., Fan, Z., García, A. M., Welch, A. E., Ratnasiri, B. M., Wilson, S. M., Henry, M. L., Vonk, J., Deleon, J., Miller, B. L., et al. (2024) · Cortex · doi:10.1016/j.cortex.2023.12.013 · Cited by 19
Self-citationLima-Silva, T. B., Mioshi, E., Bahia, V. S., Cecchini, M. A., Cassimiro, L., Guimarães, H. C., Gambogi, L. B., Caramelli, P., Balthazar, M., Damasceno, B., et al. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720944239 · Cited by 18
“Changes in imaging parameters were significantly correlated with change and explained a substantial portion of variance, in most clinical measures.(34) The slower progression in semantic variant PPA, also observed in our study (tentatively due to small sample size), is in line with the prolonged survival shown in a co…”
ResultLiu, A. J., Staffaroni, A. M., Rojas-Martinez, J. C., Olney, N. T., Alquezar-Burillo, C., Ljubenkov, P. A., La Joie, R., Fong, J. C., Taylor, J., Karydas, A., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4284 · Cited by 18
Self-citationNeuroimaging in Frontotemporal Lobar Degeneration: Research and Clinical Utility
Dev, S. I., Dickerson, B. C., & Touroutoglou, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_7 · Cited by 18
Self-citationSavard, M., Pascoal, T. A., Servaes, S., Dhollander, T., Iturria‐Medina, Y., Kang, M. S., Vitali, P., Therriault, J., Mathotaarachchi, S. S., Benedet, A. L., et al. (2022) · eLife · doi:10.7554/elife.73510 · Cited by 17
Asken, B. M., Ljubenkov, P. A., Staffaroni, A. M., Casaletto, K. B., Vandevrede, L., Cobigo, Y., Rojas-Rodriguez, J. C., Rankin, K. P., Kornak, J., Heuer, H., et al. (2023) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-330866 · Cited by 16
Self-citationBiomarkers in ALS trials: from discovery to clinical utility
Roy, T., Al‐Chalabi, A., Iacoangeli, A., & Khleifat, A. A. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1636303 · Cited by 19
Ssali, T., Anazodo, U., Narciso, L., Liu, L., Jesso, S., Richardson, L., Günther, M., Konstandin, S., Eickel, K., Prato, F. S., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102853 · Cited by 17
“Furthermore, longitudinal reductions in perfusion by ASL have been detected in FTD patients (Staffaroni et al., 2019a) and are associated with clinical measures of cognitive decline (Staffaroni et al., 2019b), highlighting the potential for ASL for longitudinal assessments.”
BackgroundAnomaly detection for the individual analysis of brain PET images
Burgos, N., Cardoso, M. J., Samper‐Gonzàlez, J., Habert, M., Durrleman, S., Ourselin, S., & Colliot, O. (2021) · Journal of medical imaging · doi:10.1117/1.jmi.8.2.024003 · Cited by 19
“46,47 The subjects ’ demographic characteristics and clinical scores are shown in Fig.”
BackgroundTripartite Relationship Among Synaptic, Amyloid, and Tau Proteins: An In Vivo and Postmortem Study
Casaletto, K. B., Zetterberg, H., Blennow, K., Brinkmalm, A., Honer, W. G., Schneider, J. A., Bennett, D. A., Djukic, N. A., You, M. Y., Weiner‐Light, S., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012145 · Cited by 14
“See Supplemental Methods for additional measure information.”
BackgroundSelf-citationRanasinghe, K. G., Toller, G., Cobigo, Y., Chiang, K., Callahan, P., Eliazer, C., Kramer, J. H., Rosen, H. J., Miller, B. L., & Rankin, K. P. (2021) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12183 · Cited by 13
Self-citationMorrow, C. B., Kamath, V. J., Dickerson, B. C., Eldaief, M. C., Rezaii, N., Wong, B., McGinnis, S. M., Darby, R., Staffaroni, A. M., Lapid, M. I., et al. (2025) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13810 · Cited by 14
“8,9 If NPS correlate with bvFTD stage, they will provide helpful staging information; however, if they fl uctuate in bvFTD as they do in PPD or in AD, they are not likely to be reliable markers of disease progression.”
Self-citationPérez‐Millan, A., Contador, J., Tudela, R., Niñerola‐Baizán, A., Setoaín, X., Lladó, A., Sánchez‐Valle, R., & Sala‐Llonch, R. (2022) · Scientific Reports · doi:10.1038/s41598-022-18129-4 · Cited by 14
Predicting disease progression in behavioral variant frontotemporal dementia
Anderl‐Straub, S., Lausser, L., Lombardi, J., Uttner, I., Fassbender, K., Fliessbach, K., Huppertz, H., Jahn, H., Kornhuber, J., Obrig, H., et al. (2021) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12262 · Cited by 11
Magnetic Resonance Imaging in Tauopathy Animal Models
Ni, R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.791679 · Cited by 11
“…blood oxygenation (arterial blood pressure of oxygen), ventilation (arterial partial pressure of carbon dioxide), and arterial blood pressure, can influence BOLD fMRI readouts in various study designs (Steiner et al., 2020) and are thus recommended for inclusion in the monitoring of animal status.”
BackgroundGonzalez-Gomez, R., Ibañez, A., & Moguilner, S. (2023) · Network Neuroscience · doi:10.1162/netn_a_00285 · Cited by 10
“…the clinical diagnosis of each frontotemporal dementia (FTD) variant requires high levels of expertise and multidisciplinary teams to distinguish among subtle phenotypes with similar underlying physiopathological processes (Bejanin et al., 2020; Staffaroni et al., 2019; Zetterberg et al., 2019).”
Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patients
Assogna, M., Lorenzo, F. D., Bonnì, S., Borghi, I., Irelli, E. C., Mencarelli, L., Maiella, M., Minei, M., Esposito, R., Casula, E. P., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf080 · Cited by 12
“20,21 The decision to prioritize CDR plus NACC FTLD—SoB was made by the Principal Investigator (G.K.) independently of trial data and prior to unblinding.”
Functional and structural network changes related with cognition in semantic dementia longitudinally
Huang, L., Cui, L., Chen, K., Han, Z., & Guo, Q. (2023) · Human Brain Mapping · doi:10.1002/hbm.26345 · Cited by 10
“Only a minority follow-up studies to date have been somewhat limited by small sample size (Bejanin et al., 2020; Binney et al., 2017; Cousins et al., 2018; Kumfor et al., 2016; Staffaroni et al., 2019; Younes et al., 2022), and even none containing both functional and structural network analysis.”
BackgroundChatzidimitriou, E., Chen, Y., Μoraitou, D., Ioannidis, P., Aretouli, E., Kramer, J. H., Miller, B. L., Gorno‐Tempini, M., Seeley, W. W., Rosen, H. J., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13254-2 · Cited by 9
“Baseline structural brain imaging, serum neurofilament light chain (NfL) levels, and transcranial magnetic stimulation (TMS) have all been shown to effectively predict longitudinal functional decline in bvFTD [50–53].”
Self-citationFieldhouse, J. L. P., van Paassen, D. N., van Engelen, M.-P. E., De Boer, S. C. M., Hartog, W. L., Braak, S., Schoonmade, L. J., Schouws, S. N. T. M., Krudop, W. A., Oudega, M. L., et al. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1382593 · Cited by 8
Çayır, S., Volpi, T., Toyonaga, T., Gallezot, J., Yang, Y., Sadabad, F. E., Mulnix, T., Mecca, A. P., Fesharaki‐Zadeh, A., & Matuskey, D. (2024) · Journal of Neuroimaging · doi:10.1111/jon.13206 · Cited by 8
“8,12,18 The heterogeneity of our study population might be part of the explanation.”
Michelutti, M., Huppertz, H., Volkmann, H., Anderl‐Straub, S., Urso, D., Tafuri, B., Nigro, S. L., Manganotti, P., Werner, L., Lombardi, J., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13215-9 · Cited by 9
“These findings are consistent with the critical role of frontal lobe white matter in executive and language functions commonly impaired in both nfPPA and svPPA and with the established role of temporal regions in semantic processing [33, 38, 39].”
Value of MRI Outcomes for Preventive and Early‐Stage Trials in Spinocerebellar Ataxias 1 and 3
de Rezende, T. J. R., Petit, E., Park, Y. W., du Montcel, S. T., Joers, J. M., DuBois, J. M., Arnold, H. M., Považan, M., Özdemir, İ., Banan, G., et al. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70325 · Cited by 8
Dial, H. R., Europa, E., Grasso, S. M., Mandelli, M. L., Schaffer, K. M., Hubbard, H. I., Wauters, L., Wineholt, L., Wilson, S. M., Gorno‐Tempini, M. L., et al. (2022) · Cortex · doi:10.1016/j.cortex.2022.10.004 · Cited by 7
Self-citationRizzi, L., Aventurato, Í. K., & Balthazar, M. L. F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.640525 · Cited by 8
Gordón, E., Bocchetta, M., Nicholas, J. M., Cash, D. M., & Rohrer, J. D. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102842 · Cited by 6
Koch, G., Assogna, M., Gadola, Y., Alberici, A., Lorenzo, F. D., Bonnì, S., Borghi, I., Irelli, E. C., Mencarelli, L., Maiella, M., et al. (2025) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2025.101409 · Cited by 6
“…dysfunction in FTD, our findings align with previous research suggesting that the NPI should not be regarded as a reliable measure in this syndrome when used to detect behavioral changes within a time frame of 6 months, 29,30 possibly due to the inter-subject variability of behavioral phenotypes.”
InfluentialModeling contributions of cognition and apathy to functional impairment in younger‐onset dementia
Warren, S. L., Ahmed, R. M., Piguet, O., Foxe, D., & Irish, M. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70249 · Cited by 5
“Notably, functional impairment was tightly coupled with apathy early in the disease course of SD and PNFA, yet plateaued at a “moderate” level of severity on the FRS once a critical threshold was reached (CBI-Apathy > 10).”
Olm, C. A., Burke, S., Peterson, C. S., Lee, E. B., Trojanowski, J. Q., Massimo, L. M., Irwin, D. J., Grossman, M., & Gee, J. C. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103285 · Cited by 6
“Though MMSE is regularly shown to be impaired in patients with FTLD and worsens over time (Bian et al., 2008; Cousins et al., 2021; Tan et al., 2013), we did not find such an association.”
BackgroundTuovinen, T., Häkli, J., Rytty, R., Krüger, J., Korhonen, V. O., Järvelä, M., Helakari, H., Kananen, J., Nikkinen, J., Veijola, J., et al. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241262583 · Cited by 5
Self-citationThe Potential of Disease Progression Modeling to Advance Clinical Development and Decision Making
Starling, S., Kehoe, L. S., Burnett, B. K., Green, P., Venkatakrishnan, K., & Madabushi, R. (2024) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3467 · Cited by 7
Quinn, C., Craik, A., Tessmer, R., Henry, M. L., & Dial, H. R. (2025) · Neuroimage Reports · doi:10.1016/j.ynirp.2025.100242 · Cited by 4
“…with PPA met diagnostic criteria for PPA and for PPA subtype (Gorno-Tempini et al., 2011) as determined by a comprehensive neurological, neuropsychological, and cognitive-Quinn linguistic assessment (Gorno-Tempini et al., 2004; Kramer et al., 2003; Knopman et al., 2008; Staffaroni et al., 2019).”
Dial, H. R., Pugalenthi, L. S., Gnanateja, G. N., Li, J. J., & Henry, M. L. (2025) · Scientific Reports · doi:10.1038/s41598-025-13000-8 · Cited by 4
“…significant differences across PPA subtypes on the MMSE, F (2, 28) = 2.62, p = 0.091. a Assessments from neuropsychological battery described in 41–43 gyrus is a site of prominent atrophy in lvPPA 62 , we sought to determine whether cortical tracking of the broad-band envelope derivative would be…”
InfluentialThe presymptomatic and early manifestations of semantic dementia
Whiteside, D. J., Rouse, M. A., Jones, P. S., Coyle-Gilchrist, I. T. S., Murley, A. G., Stockton, K. C., Hughes, L. E., Bethlehem, R. A. I., Warrier, V., Ralph, M. A. L., et al. (2025) · Brain · doi:10.1093/brain/awaf351 · Cited by 3
“Our out-of-sample test set for the classifier consisted of participants in the Neuroimaging in Frontotemporal Dementia study (NIFD, also known as the frontotemporal lobar degeneration neuroimaging initiative, http://memory.ucsf.edu/research/studies/ nifd)36 and ADNI 3 (adni.loni.usc.edu).”
InfluentialMRI ‐ DTI Biomarkers Along the Continuum of Behavioral Variant Frontotemporal Dementia
Michelutti, M., Huppertz, H., Anderl‐Straub, S., Volkmann, H., Urso, D., Tafuri, B., Nigro, S. L., Manganotti, P., Rosenbohm, A., Ludolph, A. C., et al. (2025) · European Journal of Neurology · doi:10.1111/ene.70438 · Cited by 4
Clinical Trial Development in Frontotemporal Lobar Degeneration
Ljubenkov, P. A., & Boxer, A. L. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.019 · Cited by 3
Self-citationDriver, I. D., Chandler, H. L., Patitucci, E., Morgan, E. L., Murphy, K., Zappalá, S., Wise, R. G., & Germuska, M. A. (2025) · Imaging Neuroscience · doi:10.1162/imag_a_00506 · Cited by 3
“It is being used to further our understanding of physiological mechanisms in both the brain (Haller et al., 2016; Liang et al., 2013; Mattsson et al., 2014; Satterthwaite et al., 2014; Segerdahl et al., 2015; Staffaroni et al., 2019) and body (Taso et al., 2023).”
Integrating a motor domain enhances disease severity scales in an FTD‐ALS spectrum cohort
Snyder, A. G., Samra, K., Wu, T., Russell, L. L., Farren, J., Crook, J., Haselhuhn, T., Porter, K., Szabo, M. P., Duckett, A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70786 · Cited by 2
Self-citationSpeech perception and language comprehension in primary progressive aphasia
Dial, H. R., Tessmer, R., & Henry, M. L. (2024) · Cortex · doi:10.1016/j.cortex.2024.10.010 · Cited by 1
Diagnosis and management of frontotemporal dementia: a narrative review
Cenacchi, V., Lombardo, T., Palacino, F., Cattaruzza, T., Manganotti, P., & Benussi, A. (2026) · Neurodegenerative Disease Management · doi:10.1080/17582024.2026.2687481 · Cited by 2
Naik, M., Esmaeili, M., Thomas, O. M. T., & Geitung, J. T. (2021) · Acta Radiologica Open · doi:10.1177/20584601211066467 · Cited by 1
“One study has shown for the first time that the integrity of specific white matter tracts is a mediator of age-related changes in cognitive performance.(19) In this article, we investigate whether MRI with FA can be of use in differential diagnoses for people with AD and behavioral symptoms (frontal lobe symptoms).”
BackgroundResultAlnaser, F. A. (2022) · Recent Advances in Clinical Trials · doi:10.33425/2771-9057.1015 · Cited by 1
“Symptoms of FTD include personal and behavioral changes such as impulsivity and loss of motivation, language problems such as slow speech, and mental and memory problems [21].”
BackgroundStructural gray matter changes in primary progressive aphasia variants
Akhmadullina, D. R., Коновалов, Р. Н., Shpilyukova, Y. A., & Fedotova, E. Y. (2023) · Digital Diagnostics · doi:10.17816/dd567783 · Cited by 1
“Кроме того, нейровизуализация может использоваться для отслеживания терапевтического эффекта разрабатываемых методов лечения [3, 7, 8].”
Colyer‐Patel, K., Teeuw, J., Maes, V., Goossens, V., Brouwer, R. M., Jahanshad, N., Thompson, P. M., & Pol, H. E. H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.15.669078 · Cited by 3
WITHDRAWN: Frontotemporal Dementia: A systematic reviewPreprint
Khalifa, S. (2021) · Research Square · doi:10.21203/rs.3.rs-1156339/v1
“variance explained by volume alone, arguing for considering multimodal imaging in treatment trials [2].”
BackgroundInfluentialTippett, D. C. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736383853.793569920
Advances in Primary Progressive Aphasia
Matías‐Guiu, J. A., Laforce, R. J., & Utianski, R. L. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-4407-6
Katsumi, Y., Brickhouse, M. J., Hanford, L. C., Nielsen, J. A., Elliott, M. L., Mair, R. W., Touroutoglou, A., Eldaief, M. C., Buckner, R. L., & Dickerson, B. C. (2025) · medRxiv · doi:10.1101/2025.03.14.25323769
Self-citationPak, V., Hong, J. H., Baumeister, T. R., Bezgin, G., Nagy, C., Ducharme, S., Dadar, M., Zeighami, Y., & Iturria‐Medina, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.21.665217
“Histological analysis was also conducted to assess potential Alzheimer’s disease pathology, due to overlapping clinical symptoms between the conditions 111 .”
InfluentialMicrostructural grey matter alterations in patients with behavioural variant frontotemporal dementia
Akbarian, B., Hett, K., Phan, T. X., Lee, J. J., Eaton, J. E., Donahue, M. J., & Darby, R. R. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf427
The Behavioral Variant of Frontotemporal Dementia: Preclinical to Advanced Dementia
Illán‐Gala, I., & Miller, B. L. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.011
Self-citationTreatment of Frontotemporal Dementias
Chen, D., VandeVrede, L. A., & Boxer, A. L. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.022
Self-citationMacIver, P. H. (2024) · Maryland Shared Open Access Repository (USMAI Consortium) · doi:10.13016/m238rj-jg5b
Liu, X. (2023) · Apollo (University of Cambridge) · doi:10.17863/cam.106430
Ding, W., Ren, P., Yi, L., Si, Y., Yang, F., Li, Z., Bao, H., Yan, S., Zhang, X., Li, S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22620649
Early regional hypometabolism in presymptomatic MAPT carriers : a GENFI sub-study
St-Onge, F. (2019) · Corpus Université Laval (Université Laval)
Katsumi, Y., Brickhouse, M. J., Hanford, L. C., Nielsen, J. A., Elliott, M. L., Mair, R. W., Touroutoglou, A., Eldaief, M. C., Buckner, R. L., & Dickerson, B. C. (2026) · Imaging Neuroscience · doi:10.1162/imag.a.1138
“…stages of AD or FTLD ( Anderl-Straub et al., 2021; Bakkour et al., 2009; Dickerson & Wolk, 2013; Katsumi et al., 2023, 2024; Keret et al., 2021; Staffaroni et al., 2019) as well as individuals who develop these syndromes but were scanned when cognitively unimpaired ( Dickerson et al., 2011;…”
Self-citationKatsumi, Y., Krahn, E. A., Paranhos, T., Brickhouse, M. J., Rosen, H. J., Touroutoglou, A., Dickerson, B. C., Eldaief, M. C., & Initiative, F. T. F. L. D. N. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70258 · Cited by 1
“11,13,15 44 Some studies examined a broader set of anatomically defined ROIs or whole-brain/whole-cortex voxel-wise analyses, 4,9,45 althoughonlyafewoftheminterpretedtheirfindingsthroughthelens of the spread of neuropathologic changes or structural deterioration over time.”
Self-citationMusrah, A. T. S., Nugraha, D. D., Kumfor, F., & Piguet, O. (2026) · Cortex · doi:10.1016/j.cortex.2026.03.009
Metadata
- Authors
- Staffaroni, A. M., Ljubenkov, P. A., Kornak, J., Cobigo, Y., Datta, S., Marx, G., Walters, S. M., Chiang, K., Olney, N., Elahi, F. M., Knopman, D. S., Dickerson, B. C., Boeve, B. F., Gorno-Tempini, M. L., Spina, S., Grinberg, L. T., Seeley, W. W., Miller, B. L., Kramer, J. H., Boxer, A. L., & Rosen, H. J.
- Affiliations
- University of California, San Francisco (US)
- Mayo Clinic (US)
- Harvard University (US)
- Department of Neurology, Memory and Aging Center, University of California at San Francisco (UCSF), San Francisco, CA, USA
- Universidade de São Paulo (BR)
- Corresponding author
- Staffaroni, Adam M
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-01-29
- Volume
- 142
- Issue
- 2
- Pages
- 443-459
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6351779
- OpenAlex
- W2912954741
- Cited by
- 105
- References
- 69
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 10 · 2023: 14 · 2022: 15 · 2021: 19 · 2020: 12 · 2019: 8
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (AG045333, AG045390, AG032306, AG019724, AG023501)
- Hillblom Network
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- frontotemporal dementia, clinical trial endpoints, longitudinal neuroimaging, multimodal imaging, diffusion tensor imaging, cortical atrophy, white matter microstructure, behavioral variant frontotemporal dementia, primary progressive aphasia, semantic variant, neuropsychological decline, functional decline, sample size determination, biomarkers, tau protein, TDP-43
- MeSH terms
- Aged, Cross-Sectional Studies, Female, Follow-Up Studies, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Endpoint Determination, Diffusion Tensor Imaging, Frontotemporal Dementia, Multimodal Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.